Dr. George Saade, M.D

NPI: 1114089489
Total Payments
$111,910
2024 Payments
$15,987
Companies
12
Transactions
95

Payment Breakdown by Category

Consulting$90,086 (80.5%)
Travel$12,658 (11.3%)
Other$4,800 (4.3%)
Food & Beverage$2,250 (2.0%)
Research$1,672 (1.5%)
Education$444.63 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $90,086 36 80.5%
Travel and Lodging $12,658 13 11.3%
Honoraria $4,800 2 4.3%
Food and Beverage $2,250 26 2.0%
Unspecified $1,672 11 1.5%
Education $444.63 7 0.4%

Payments by Type

General
$110,238
84 transactions
Research
$1,672
11 transactions

Top Paying Companies

Company Total Records Latest Year
AMAG Pharmaceuticals, Inc. $50,672 46 $0 (2022)
Organon LLC $17,157 12 $0 (2023)
GlaxoSmithKline, LLC. $15,604 5 $0 (2024)
MEDICEM INC. $13,902 14 $0 (2023)
PFIZER INC. $5,291 4 $0 (2019)
CooperSurgical, Inc. $3,940 6 $0 (2022)
Ferring Pharmaceuticals Inc. $2,860 3 $0 (2018)
Janssen Research & Development, LLC $2,100 1 $0 (2022)
Monaghan Medical Corporation $181.79 1 $0 (2024)
Northgate Technologies, Inc. $134.30 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $15,987 9 GlaxoSmithKline, LLC. ($15,604)
2023 $15,481 13 Organon LLC ($15,357)
2022 $35,829 7 AMAG Pharmaceuticals, Inc. ($31,500)
2021 $3,910 5 CooperSurgical, Inc. ($3,910)
2020 $3,436 5 Medicem Inc. ($3,188)
2019 $30,151 43 AMAG Pharmaceuticals, Inc. ($14,666)
2018 $2,962 4 Ferring Pharmaceuticals Inc. ($2,860)
2017 $4,156 9 AMAG Pharmaceuticals, Inc. ($4,156)

All Payment Transactions

95 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
10/21/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $3,900.00 General
10/11/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $3.90 General
09/09/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $1,950.00 General
08/20/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $5,200.00 General
07/30/2024 Northgate Technologies, Inc. Stimsite (Device) Food and Beverage Cash or cash equivalent $134.30 General
Category: General Surgery
07/24/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $4,550.00 General
03/21/2024 Hologic Sales and Service, LLC APTIMA (Device) Food and Beverage In-kind items and services $19.58 General
Category: Diagnostics
03/19/2024 Monaghan Medical Corporation AeroEclipse (Device) Food and Beverage In-kind items and services $181.79 General
Category: Nebulizer
02/07/2024 NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. Hera W10 (Device) Food and Beverage Cash or cash equivalent $47.16 General
Category: UltraSound
07/26/2023 Organon LLC Consulting Fee Cash or cash equivalent $7,650.00 General
04/26/2023 Organon LLC Consulting Fee Cash or cash equivalent $6,000.00 General
04/26/2023 Organon LLC Food and Beverage In-kind items and services $11.75 General
04/25/2023 Organon LLC Travel and Lodging In-kind items and services $299.73 General
04/25/2023 Organon LLC Food and Beverage In-kind items and services $107.88 General
04/25/2023 Organon LLC Food and Beverage In-kind items and services $39.00 General
04/25/2023 Organon LLC Food and Beverage In-kind items and services $27.25 General
04/24/2023 Organon LLC Travel and Lodging In-kind items and services $368.66 General
04/24/2023 Organon LLC Travel and Lodging In-kind items and services $299.73 General
04/24/2023 Organon LLC Travel and Lodging In-kind items and services $84.39 General
04/23/2023 Organon LLC Travel and Lodging In-kind items and services $468.80 General
01/25/2023 MEDICEM INC. DILAPAN-S (Device) Food and Beverage In-kind items and services $61.66 General
Category: SURGERY
01/25/2023 MEDICEM INC. DILAPAN-S (Device) Food and Beverage In-kind items and services $61.66 General
Category: SURGERY
12/21/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $31,500.00 General
Category: Reduction of risk for preterm birth
11/04/2022 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $2,100.00 General
09/16/2022 Organon LLC Honoraria Cash or cash equivalent $1,800.00 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia AMAG Pharmaceuticals, Inc. $1,672 11

About Dr. George Saade, M.D

Dr. George Saade, M.D is a Maternal & Fetal Medicine healthcare provider based in Galveston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114089489.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Saade, M.D has received a total of $111,910 in payments from pharmaceutical and medical device companies, with $15,987 received in 2024. These payments were reported across 95 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($90,086).

Practice Information

  • Specialty Maternal & Fetal Medicine
  • Location Galveston, TX
  • Active Since 12/14/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207VM0101X
  • Entity Type Individual
  • NPI Number 1114089489

Products in Payments

  • MAKENA (Drug) $49,000
  • DILAPAN-S (Device) $13,902
  • Uterine Manipulators & Injectors (Device) $3,850
  • CERVIDIL (Drug) $2,860
  • AeroEclipse (Device) $181.79
  • Stimsite (Device) $134.30
  • Obstetrical Products (Device) $60.00
  • Hera W10 (Device) $47.16
  • Summit Doppler (Device) $30.00
  • APTIMA (Device) $19.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Maternal & Fetal Medicine Doctors in Galveston